Each molecular subtype of NCL shows remarkable phenotypic heterogeneity with respect to age of onset, severity of clinical features, and their order of presentation, raising the possibility of genetic modifiers that converge on NCL-associated pathways. The gene discussed is NUCLEOLIN; the disease is neuronal ceroid lipofuscinosis.